Adverse Business Developments Sample Clauses

The Adverse Business Developments clause requires a party, typically the seller in a transaction, to disclose any significant negative changes or events affecting its business. This can include financial losses, legal proceedings, regulatory investigations, or loss of key customers that occur before the deal closes. By mandating such disclosures, the clause ensures that the other party is kept informed of material risks or issues, thereby protecting them from unforeseen liabilities and supporting informed decision-making.
Adverse Business Developments. No notice has been received by Seller or any Shareholder of any new or substantially expanded firm or individual engaged in a business directly competitive to Seller in its primary service area within six (6) months before the date hereof. Neither Seller nor any Shareholder has received, either orally or in writing, any notice specific to it of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payor reimbursement method, practice or allowance as to any business activity engaged in by Seller, nor has Seller or any Shareholder received, or been threatened with, any claim for refund specific to it in excess of $500.00 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Proceedings attached hereto as Schedule 13(q).
Adverse Business Developments. No notice has been received by ----------------------------- the Seller of any new or substantially expanded firm or individual engaged in a business directly competitive to Seller in its primary service area within six (6) months prior to the date hereof. Nor has Seller received, either orally or in writing, any notice specific to Seller of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payor reimbursement method, practice or allowance as to any business activity engaged by Seller, nor has Seller received nor been threatened with any claim for refund specific to Seller in excess of $500.00 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Proceedings attached hereto as Exhibit "Q," which may have a material adverse effect on Seller.
Adverse Business Developments. None of the Corporations nor any Stockholder has received, either orally or in writing, any notice of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payer reimbursement method, practice or allowance as to any business activity engaged by any such Corporation, nor has any such Corporation or any Stockholder received nor been threatened with any claim for refund in excess of $500 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Adverse Business Developments attached hereto as Exhibit 6-Z.
Adverse Business Developments. No notice has been received by Seller ----------------------------- of any new or substantially expanded firm or individual engaged in a business directly competitive to Seller in its primary service area within six (6) months prior to the date hereof. Nor has Seller received, either orally or in writing, any notice specific to Seller of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payor reimbursement method, practice or allowance as to any business activity engaged by Seller, nor has Seller received nor been threatened with any material claim for refund specific to Seller by a Medicare or Medicaid carrier.
Adverse Business Developments. No notice has been received by the Company, the Subsidiary, any Guarantor or Shareholder of any new or substantially expanded firm or individual engaged in a business directly competitive to the Company or the Subsidiary in its primary service area within six (6) months before the date hereof that the Company, the Subsidiary, any Guarantor or Subsidiary reasonably believes will have a material adverse effect on the Business. None of the Company, the Subsidiary, the Guarantors and Shareholders has received, either orally or in writing, any notice specific to it of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payor reimbursement method, practice or allowance as to any business activity engaged in by the Company or the Subsidiary, nor has the Company, the Subsidiary, any Guarantor or any Shareholder received, or been threatened with, any claim for refund specific to it in excess of $750 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Proceedings attached hereto as Schedule 9.17.
Adverse Business Developments. No notice has been received by the Company or any Shareholder of any new or substantially expanded firm or individual engaged in a business directly competitive to the Company in its primary service area within six (6) months before the date hereof that the Company, the Subsidiary, any Guarantor or Subsidiary reasonably believes will have a material adverse effect on the Business. None of the Company and Shareholders has received, either orally or in writing, any notice specific to it of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payor reimbursement method, practice or allowance as to any business activity engaged in by the Company, nor has the Company or any Shareholder received, or been threatened with, any claim for refund specific to it in excess of $750 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Proceedings attached hereto as Schedule 9.17.
Adverse Business Developments. Neither the Seller nor any stockholder, director, officer or employee of Seller has received, either orally or in writing, any notice of pending or threatened adverse action with respect to any Medicare, Medicaid, private insurance or third party payer reimbursement method, practice or allowance as to any business activity engaged by Seller, nor has the Seller or any stockholder, director, officer or employee of Seller received nor been threatened with any claim for refund in excess of $500 by a Medicare or Medicaid carrier, except as disclosed in the Schedule of Adverse Business Developments attached hereto as EXHIBIT 7-X.